STEAP1 and gastric cancer: Thus, given its high tumor specificity and membrane-bound localization, STEAP1 is an attractive candidate for targeted therapy in gastric cancer patients with peritoneal metastasis (Hubert et al., 1999; Cheung et al., 2007; Valenti et al., 2009).